Celgene celgene.com

Celgene (NASDAQ: CELG) is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

Celgene (NASDAQ: CELG) is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solut...Show all

See All Exits Recent Exits

Phone: 908-673-9000

Fax:

86 Morris Avenue

 Summit, 07901
 New Jersey, United States

Celgene - Investments & Acquisitions

Show Real Data Celgene Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-10-10Gotham TherapeuticsSeries A$54MAlexandria Venture Investments, Forbion Capital Partners, SR One, and Versant Ventures
2018-09-19Silverback TherapeuticsSeries A - II$37.5MAlexandria Venture Investments, and OrbiMed Advisors
2018-07-17Presage BiosciencesSeries D$6MTakeda Ventures
2018-06-26Skyhawk TherapeuticsPartnership$60M
2018-06-06Sutro BiopharmaSeries E$85.4MAlta Partners, Amgen Ventures, Citadel, Eventide Asset Management, Lilly Ventures, Merck Ventures, Nexthera Capital, Samsara BioCapital, Skyline Ventures, SV Health Investors, Tekla Capital Management, and Vida Ventures
See all 5 investments